# Epigenomic and Transcriptomic Analysis in BRCA Mutated Carriers With and Without Serous Tubal Intraepithelial Carcinoma

> **NCT07736300** · NA · NOT_YET_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 30 (estimated)

## Conditions studied

- Epigenomics
- Transcriptomics
- BRCA Mutations

## Interventions

- **DIAGNOSTIC_TEST:** Peripheral blood sampling performed for germline DNA extraction and assessment of BRCA1/2 mutation status.

## Key facts

- **NCT ID:** NCT07736300
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-07-15
- **Final completion:** 2028-07-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736300, "Epigenomic and Transcriptomic Analysis in BRCA Mutated Carriers With and Without Serous Tubal Intraepithelial Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*